The heart transplant program at the University of California San Diego Health has achieved the best one-year patient…
Articles by Joana Carvalho, PhD
Treatment with nintedanib lowered lung blood pressure in a rat model of pulmonary arterial hypertension by preventing cells of…
An anti-inflammatory diet with high amounts of protein, fish oil, the amino acid leucine, and oligosaccharides reduced changes in…
Acceleron Pharma has reached its patient enrollment goal in the ongoing Phase 2 PULSAR trial, with more than…
Exposure to air pollutants may be linked to disease severity and other clinical outcomes in people with pulmonary arterial…
The U.S. Food and Drug Administration (FDA) has approved Novitium Pharma‘s generic sildenafil for oral suspension at a…
Treatment with Revatio (sildenafil) successfully reduced symptoms of portopulmonary hypertension (PPHTN), allowing patients to undergo liver transplant safely,…
Promising preclinical findings recently published in a peer-reviewed journal opened the door to the launch of a Phase 2 trial…
Oral beraprost, in combination with standard therapy, may help decrease pulmonary arterial pressure, and improve heart function and exercise capacity in…
The U.S. Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) for Cipla‘s ambrisentan generic…
The health regulatory agency for Australia has approved Mallinckrodt Pharmaceuticals‘ INOmax (nitric oxide) gas for inhalation as a…
Combined therapy with Revatio (sildenafil) and Opsumit (macitentan) was effective in…